Skip to content

Clinical trials

Phase 1/2 Dementia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 1/2 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20071
20081
20101
20121
20131
20141
20191
20204
20213
20223
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting7
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital2
AC Immune SA1
Arizona State University1
AviadoBio Ltd1
BioXcel Therapeutics Inc1
Brigham and Women's Hospital1
David Wilson1
Duke University1
Evan Thomas1
Intra-Cellular Therapies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia23
Alzheimer Disease17
Cognitive Dysfunction4
Brain Diseases2
Central Nervous System Diseases2
Down Syndrome2
Frontotemporal Dementia2
Amyotrophic Lateral Sclerosis1
Anxiety Disorders1
Aphasia, Primary Progressive1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.